Skip to main content
BioInvent International AB (publ) (STO:BINV)
Sweden flag Sweden · Delayed Price · Currency is SEK
23.10
+0.85 (3.82%)
Mar 10, 2026, 10:48 AM CET

STO:BINV Revenue

In the year 2025, BioInvent International AB had annual revenue of 226.50M SEK with 406.86% growth. BioInvent International AB had revenue of 3.02M in the quarter ending December 31, 2025, a decrease of -85.89%.

Revenue
226.50M
Revenue Growth
+406.86%
P/S Ratio
6.46
Revenue / Employee
2.08M
Employees
109
Market Cap
1.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025226.50M181.81M406.86%
Dec 31, 202444.69M-26.78M-37.47%
Dec 31, 202371.46M-254.67M-78.09%
Dec 31, 2022326.13M306.74M1,582.45%
Dec 31, 202119.38M-127.99M-86.85%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Saniona AB 434.40M
Genovis AB (publ.) 129.65M
Diamyd Medical AB 349.00K
Egetis Therapeutics AB 62.40M
Cantargia AB 316.70M
Xspray Pharma AB 6.43M
Medivir AB 8.50M
Vicore Pharma Holding AB 3.82M
Revenue Rankings

BioInvent International AB News

More News